Skip to main content
Clinical Trials/NCT00720330
NCT00720330TerminatedNot Applicable

The Effect of Thoracolumbar Paravertebral Block or Intravenous Lidocaine and Ketamine Versus Standard Care on Acute and Chronic Pain After Inguinal Herniorrhaphy

The Cleveland Clinic1 site in 1 country12 target enrollmentStarted: July 2008Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
12
Locations
1
Primary Endpoint
Postoperative Opioid Consumption in Oral Oxycodone Equivalents

Study Overview

Brief Summary

The investigators are conducting this study to find out if intravenous (injected through the vein) infusion of lidocaine and ketamine administered with general anesthesia is as effective as a paravertebral block in lessening pain after surgery and that both of these techniques are superior to general anesthesia alone in reducing pain immediately after surgery and in the long-term.

Detailed Description

Participants will be randomized into one of three study groups; Group 1 - Paravertebral Group - ropivacaine is injected near the spine before surgery. Midazolam and fentanyl are administered intravenously for sedation. Group 2 - Lidocaine/Ketamine - General anesthesia with lidocaine and ketamine administered intravenously throughout your surgery and for 60 minutes after surgery. Group 3 - General Anesthesia Alone. General anesthesia with placebo administered intravenously throughout surgery and for 60 minutes after surgery. All participants will rate their pain on a scale from 0 to 10 after surgery and on days 1 and 2 after surgery. Participants are called 3 and 6 months after surgery for pain and quality of life assessments

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age greater than 18 and less than 75 years
  • Unilateral inguinal hernia scheduled for elective open repair

Exclusion Criteria

  • Incarcerated hernia or urgent procedure
  • Reoperation (recurrent hernia)
  • Contraindication to regional anesthesia such as:
  • Coagulopathy
  • Infection at the site of needle insertion
  • Pre-existing chronic pain (at any site) requiring treatment
  • Contraindication to any study medication (local anesthetic or ketamine)
  • History of significant Axis I psychiatric disease (major depressive disorder,bipolar disorder, schizophrenia, etc.)
  • Significant hepatic (ALT or AST > 2 times normal) or renal (serum creatinine > 2 mg/dl) impairment

Arms & Interventions

Ropivacaine

Active Comparator

Paravertebral Group - A local anesthetic (ropivacaine) will be injected near the spine before surgery. Participants will also receive midazolam and fentanyl intravenously (through your vein) for sedation

Intervention: ropivacaine (Drug)

Lidocaine/ketamine

Active Comparator

Participant will receive general anesthesia through the vein before surgery. Lidocaine and ketamine will be administered intravenously throughout surgery and for 60 minutes after surgery.

Intervention: Lidocaine/Ketamine (Drug)

Placebo

Placebo Comparator

General anesthesia plus placebo. Placebo will be administered intravenously until 60 minutes after surgery

Intervention: placebo (Other)

Outcomes

Primary Outcomes

Postoperative Opioid Consumption in Oral Oxycodone Equivalents

Time Frame: 2 days after surgery

The cumulative opioid consumption after surgery until the end of second postoperative day.

Secondary Outcomes

  • Pre- and Intra-operative Opioid Consumption in Fentanyl Equivalents(From admission to the end of surgery)
  • Postoperative Nausea(After surgery until the second postoperative day.)
  • Time From the End of Surgery to Readiness for Hospital Discharge.(Until hospital discharge, assessed up to 6 months)
  • Pain Scores on Numerical Rating Scale(After surgery until the second postoperative mornings.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kenneth Cummings III, MD, MS

Principal Investigator

The Cleveland Clinic

Study Sites (1)

Loading locations...

Similar Trials